Cargando…

Gal-3 Protein Expression and Localization in Prostate Tumours

Gal-3 plays an important role in cell survival, mRNA splicing, and cell–cell and cell–matrix interactions. Depending on its cellular localization and cancer type, Gal-3 may have tumour-suppressive or tumour-promoting activities. Given the promising diagnostic role of Gal-3 in the urine of PCa patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Tânia, Macedo-Silva, Catarina, Felizardo, Diana, Fraga, João, Carneiro, Isa, Jerónimo, Carmen, Henrique, Rui, Fardilha, Margarida, Vitorino, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047320/ https://www.ncbi.nlm.nih.gov/pubmed/36975419 http://dx.doi.org/10.3390/curroncol30030206

Ejemplares similares

Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
por: Lima, Tânia, et al.
Publicado: (2022)

Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Lima, Tânia, et al.
Publicado: (2022)

Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer
por: Carneiro, Isa, et al.
Publicado: (2019)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression
por: Lobo, João, et al.
Publicado: (2020)

From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research
por: Korrodi-Gregório, Luís, et al.
Publicado: (2016)

Protein Aggregation Patterns Inform about Breast Cancer Response to Antiestrogens and Reveal the RNA Ligase RTCB as Mediator of Acquired Tamoxifen Resistance
por: Direito, Inês, et al.
Publicado: (2021)

The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers
por: Leitão, Catarina, et al.
Publicado: (2022)

GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
por: Lima, Ana Rita, et al.
Publicado: (2018)

The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2019)

Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype
por: Vieira-Silva, Tânia Soraia, et al.
Publicado: (2019)

Epigenetic Markers for Molecular Detection of Prostate Cancer
por: Costa, Vera L., et al.
Publicado: (2007)

Tracking Prostate Carcinogenesis over Time through Urine Proteome Profiling in an Animal Model: An Exploratory Approach
por: Moreira-Pais, Alexandra, et al.
Publicado: (2022)

From Therapy Resistance to Targeted Therapies in Prostate Cancer
por: Moreira-Silva, Filipa, et al.
Publicado: (2022)

The Clinicopathological Significance of BiP/GRP-78 in Breast Cancer: A Meta-Analysis of Public Datasets and Immunohistochemical Detection
por: Direito, Inês, et al.
Publicado: (2022)

Downregulation of m(6)A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness
por: Guimarães‐Teixeira, Catarina, et al.
Publicado: (2022)

Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS
por: Lima, Ana Rita, et al.
Publicado: (2018)

Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2020)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021)

Uncovering potential downstream targets of oncogenic GRPR overexpression in prostate carcinomas harboring ETS rearrangements
por: Santos, Joana, et al.
Publicado: (2015)

The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2018)

Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
por: Lobo, João, et al.
Publicado: (2020)

Targeting the Immune system and Epigenetic Landscape of Urological Tumors
por: Lobo, João, et al.
Publicado: (2020)

Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer
por: Lopes, Nair, et al.
Publicado: (2021)

MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis
por: Barros-Silva, Daniela, et al.
Publicado: (2018)

Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances
por: Lourenço, Catarina, et al.
Publicado: (2021)

TGF-β cascade regulation by PPP1 and its interactors –impact on prostate cancer development and therapy
por: Korrodi-Gregório, Luís, et al.
Publicado: (2014)

Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
por: Ramalho-Carvalho, João, et al.
Publicado: (2017)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
por: Moreira-Barbosa, Catarina, et al.
Publicado: (2018)

Sirtuins’ Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
por: Roška, Jan, et al.
Publicado: (2023)

Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
por: Lobo, João, et al.
Publicado: (2021)

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
por: Flores, Bianca C. T., et al.
Publicado: (2021)

A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
por: Vieira, Filipa Quintela, et al.
Publicado: (2015)

JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma
por: Macedo-Silva, Catarina, et al.
Publicado: (2020)

Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients
por: Maia, Sofia, et al.
Publicado: (2015)

Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It?
por: Teixeira-Marques, Ana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nif0tkhooclkqvdb3oejlli5v2